Market Closed -
Nasdaq
04:00:00 2024-07-12 pm EDT
|
5-day change
|
1st Jan Change
|
6.4
USD
|
+3.06%
|
|
+0.16%
|
+7.53%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
46.93
|
70.91
|
41.18
|
18.27
|
35.73
|
41.24
|
-
|
-
|
Enterprise Value (EV)
1 |
46.93
|
70.91
|
41.18
|
18.27
|
35.73
|
41.24
|
41.24
|
41.24
|
P/E ratio
|
-1.03
x
|
-2.6
x
|
-2.01
x
|
-0.82
x
|
-1.74
x
|
-4.22
x
|
-10.7
x
|
40
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
19.6
x
|
20.3
x
|
7.55
x
|
2.13
x
|
2.23
x
|
1.68
x
|
1.17
x
|
0.83
x
|
EV / Revenue
|
19.6
x
|
20.3
x
|
7.55
x
|
2.13
x
|
2.23
x
|
1.68
x
|
1.17
x
|
0.83
x
|
EV / EBITDA
|
-1.2
x
|
-
|
-2.09
x
|
-0.82
x
|
-1.95
x
|
-3.98
x
|
-7.37
x
|
-
|
EV / FCF
|
-1.04
x
|
-
|
-
|
-1.1
x
|
-2.4
x
|
-5.41
x
|
-27.9
x
|
4.76
x
|
FCF Yield
|
-96.2%
|
-
|
-
|
-91.1%
|
-41.6%
|
-18.5%
|
-3.59%
|
21%
|
Price to Book
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Nbr of stocks (in thousands)
|
1,968
|
3,030
|
4,713
|
4,745
|
6,002
|
6,444
|
-
|
-
|
Reference price
2 |
23.85
|
23.40
|
8.737
|
3.851
|
5.952
|
6.400
|
6.400
|
6.400
|
Announcement Date
|
3/23/20
|
3/11/21
|
3/10/22
|
3/8/23
|
3/13/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
2.39
|
3.496
|
5.451
|
8.592
|
16.03
|
24.53
|
35.17
|
49.92
|
EBITDA
1 |
-38.98
|
-
|
-19.66
|
-22.33
|
-18.31
|
-10.35
|
-5.593
|
-
|
EBIT
1 |
-46.09
|
-24.75
|
-20.04
|
-22.87
|
-19.27
|
-10.86
|
-4.686
|
1.785
|
Operating Margin
|
-1,928.41%
|
-707.95%
|
-367.68%
|
-266.22%
|
-120.21%
|
-44.27%
|
-13.32%
|
3.58%
|
Earnings before Tax (EBT)
1 |
-45.13
|
-24.68
|
-18.07
|
-22.59
|
-19.02
|
-10.6
|
-4.62
|
1.785
|
Net income
1 |
-45.15
|
-23.51
|
-17.22
|
-22.16
|
-18.83
|
-10.51
|
-4.62
|
1.785
|
Net margin
|
-1,889.04%
|
-672.55%
|
-315.86%
|
-257.94%
|
-117.49%
|
-42.83%
|
-13.14%
|
3.58%
|
EPS
2 |
-23.10
|
-9.000
|
-4.350
|
-4.690
|
-3.420
|
-1.516
|
-0.6000
|
0.1600
|
Free Cash Flow
1 |
-45.14
|
-
|
-
|
-16.64
|
-14.87
|
-7.624
|
-1.479
|
8.662
|
FCF margin
|
-1,888.54%
|
-
|
-
|
-193.73%
|
-92.79%
|
-31.08%
|
-4.21%
|
17.35%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
485.27%
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
3/23/20
|
3/11/21
|
3/10/22
|
3/8/23
|
3/13/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
---|
Net sales
1 |
1.491
|
1.899
|
2.157
|
1.976
|
2.56
|
2.78
|
3.551
|
4.508
|
5.191
|
5.443
|
5.602
|
6.323
|
7.161
|
8.55
|
9.045
|
EBITDA
1 |
-5.377
|
-5.475
|
-5.679
|
-5.403
|
-5.769
|
-6.075
|
-4.458
|
-3.835
|
-3.731
|
-3.643
|
-3.019
|
-2.175
|
-1.516
|
-
|
-
|
EBIT
1 |
-5.472
|
-5.581
|
-5.82
|
-5.556
|
-5.917
|
-6.197
|
-4.988
|
-4.126
|
-3.958
|
-3.849
|
-2.928
|
-2.288
|
-1.796
|
-1.44
|
-0.43
|
Operating Margin
|
-367.04%
|
-293.89%
|
-269.82%
|
-281.17%
|
-231.13%
|
-222.91%
|
-140.47%
|
-91.53%
|
-76.25%
|
-70.71%
|
-52.27%
|
-36.19%
|
-25.08%
|
-16.84%
|
-4.75%
|
Earnings before Tax (EBT)
1 |
-4.921
|
-5.582
|
-5.782
|
-5.453
|
-5.776
|
-6.078
|
-4.903
|
-4.032
|
-4.007
|
-3.628
|
-2.895
|
-2.253
|
-1.76
|
-1.47
|
-0.46
|
Net income
1 |
-4.947
|
-5.582
|
-5.337
|
-5.453
|
-5.79
|
-5.867
|
-4.903
|
-4.032
|
-4.032
|
-3.506
|
-2.895
|
-2.253
|
-1.76
|
-1.47
|
-0.46
|
Net margin
|
-331.82%
|
-293.94%
|
-247.43%
|
-275.96%
|
-226.17%
|
-211.04%
|
-138.07%
|
-89.44%
|
-77.67%
|
-64.41%
|
-51.69%
|
-35.63%
|
-24.58%
|
-17.19%
|
-5.09%
|
EPS
2 |
-1.050
|
-1.200
|
-1.200
|
-1.200
|
-1.220
|
-1.240
|
-1.030
|
-0.6800
|
-0.6100
|
-0.5300
|
-0.4300
|
-0.3340
|
-0.2320
|
-0.1800
|
-0.0900
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
3/10/22
|
5/5/22
|
8/4/22
|
11/3/22
|
3/8/23
|
5/3/23
|
8/9/23
|
11/8/23
|
3/13/24
|
5/8/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-45.1
|
-
|
-
|
-16.6
|
-14.9
|
-7.62
|
-1.48
|
8.66
|
ROE (net income / shareholders' equity)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Assets
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Cash Flow per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex
1 |
0.07
|
-
|
-
|
-
|
0.21
|
0.2
|
0.3
|
-
|
Capex / Sales
|
2.92%
|
-
|
-
|
-
|
1.29%
|
0.82%
|
0.85%
|
-
|
Announcement Date
|
3/23/20
|
3/11/21
|
3/10/22
|
3/8/23
|
3/13/24
|
-
|
-
|
-
|
Average target price
23.16
USD Spread / Average Target +261.94% Consensus |
1st Jan change
|
Capi.
|
---|
| +7.53% | 41.24M | | +75.69% | 12.57B | | -24.14% | 7.4B | | -4.48% | 5.95B | | +5.70% | 5.05B | | -14.67% | 4.95B | | +19.72% | 4.29B | | -16.19% | 3.16B | | -0.87% | 2.01B | | +20.43% | 1.93B |
Medical Equipment
|